Literature DB >> 11232197

Liver injury in alpha 1-antitrypsin deficiency.

D H Perlmutter1.   

Abstract

Alpha 1-antitrypsin deficiency is the most common genetic cause of liver disease in children. It is also associated with chronic liver disease, hepatocellular carcinoma, and pulmonary emphysema in adults. Liver injury is caused by hepatotoxic effects of retention of the mutant alpha 1-antitrypsin molecule within the endoplasmic reticulum of liver cells, and emphysema is caused by uninhibited proteolytic damage to elastic tissue in the lung parenchyma. Recent studies of the biochemistry and cell biology of the mutant alpha 1-antitrypsin molecule have led to advances in understanding susceptibility to liver injury and in developing new strategies for prevention of both liver and lung disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11232197     DOI: 10.1016/s1089-3261(05)70115-x

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  4 in total

1.  Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells.

Authors:  Su Mi Choi; Yonghak Kim; Joong Sup Shim; Joon Tae Park; Rui-Hong Wang; Steven D Leach; Jun O Liu; Chuxia Deng; Zhaohui Ye; Yoon-Young Jang
Journal:  Hepatology       Date:  2013-06       Impact factor: 17.425

Review 2.  Gene correction in patient-specific iPSCs for therapy development and disease modeling.

Authors:  Yoon-Young Jang; Zhaohui Ye
Journal:  Hum Genet       Date:  2016-06-02       Impact factor: 4.132

3.  Single nucleotide polymorphism-mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in alpha1-antitrypsin deficiency.

Authors:  Shujuan Pan; Lu Huang; John McPherson; Donna Muzny; Farshid Rouhani; Mark Brantly; Richard Gibbs; Richard N Sifers
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

Review 4.  Nanodelivery in airway diseases: challenges and therapeutic applications.

Authors:  Indrajit Roy; Neeraj Vij
Journal:  Nanomedicine       Date:  2009-07-16       Impact factor: 5.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.